Model
Edge
KalVista Pharmaceuticals Inc.
KALV
Filing Type
8-K
Filing Date
6/10/2026
Updated
6/11/26, 2:45 PM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, C
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2
EX-4.2
EXHIBIT 4.2
EX-99.1
Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, C